ZA827516B - Derivatives of 4-phenyl quinazoline active on the central nervous system - Google Patents

Derivatives of 4-phenyl quinazoline active on the central nervous system

Info

Publication number
ZA827516B
ZA827516B ZA827516A ZA827516A ZA827516B ZA 827516 B ZA827516 B ZA 827516B ZA 827516 A ZA827516 A ZA 827516A ZA 827516 A ZA827516 A ZA 827516A ZA 827516 B ZA827516 B ZA 827516B
Authority
ZA
South Africa
Prior art keywords
derivatives
nervous system
central nervous
image
phenyl quinazoline
Prior art date
Application number
ZA827516A
Other languages
English (en)
Inventor
Andre Hallot
Kathleen Biziere
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA827516B publication Critical patent/ZA827516B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
ZA827516A 1981-10-21 1982-10-14 Derivatives of 4-phenyl quinazoline active on the central nervous system ZA827516B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8119767A FR2514765A1 (fr) 1981-10-21 1981-10-21 Nouveaux derives de la phenyl-4 quinazoline actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
ZA827516B true ZA827516B (en) 1983-08-31

Family

ID=9263248

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA827516A ZA827516B (en) 1981-10-21 1982-10-14 Derivatives of 4-phenyl quinazoline active on the central nervous system

Country Status (24)

Country Link
US (1) US4499092A (xx)
EP (1) EP0079810B1 (xx)
JP (1) JPS5888369A (xx)
KR (1) KR880001077B1 (xx)
AT (1) ATE17576T1 (xx)
AU (1) AU551938B2 (xx)
CA (1) CA1236102A (xx)
CS (1) CS229692B2 (xx)
DD (1) DD210040A5 (xx)
DE (1) DE3268699D1 (xx)
DK (1) DK156063C (xx)
ES (1) ES8307226A1 (xx)
FI (1) FI73982C (xx)
FR (1) FR2514765A1 (xx)
GR (1) GR76535B (xx)
HU (1) HU187579B (xx)
IE (1) IE53653B1 (xx)
IL (1) IL66960A0 (xx)
NO (1) NO164167C (xx)
NZ (1) NZ202237A (xx)
PT (1) PT75667B (xx)
SU (1) SU1299511A3 (xx)
YU (1) YU43528B (xx)
ZA (1) ZA827516B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521144A1 (fr) * 1982-02-08 1983-08-12 Sanofi Sa Nouveaux derives de la piperazinyl-2 phenyl-4 quinazoline possedant des proprietes antidepressives, methode de preparation desdits composes et medicaments en contenant
EP0664128A4 (en) * 1992-10-07 1997-12-17 Sumitomo Pharma PHARMACEUTICAL AGENT FOR INHIBITING TUMORNESCROSE FACTOR PRODUCTION.
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
ATE372324T1 (de) * 2003-04-30 2007-09-15 Inst For Pharm Discovery Inc Substituierte heteroarylverbindungen als inhibitoren von proteintyrosinphosphatasen
CA2543710A1 (en) * 2003-11-03 2005-05-12 Warner-Lambert Company Llc Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
AU2006263924A1 (en) 2005-06-27 2007-01-04 F. Hoffmann-La Roche Ag Chloro-substituted guanidines
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
RU2477046C2 (ru) 2006-11-22 2013-03-10 Сумитомо Кемикал Компани, Лимитед Агент для ингибирования сигнальной функции цитокинина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA894239A (en) * 1972-02-29 Pfizer Inc. Nitrogen heterocycles
US3305553A (en) * 1965-10-18 1967-02-21 Parke Davis & Co 2-aminoquinazoline derivatives
US3509141A (en) * 1966-09-15 1970-04-28 Ciba Geigy Corp 2-amino-quinazolines
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation

Also Published As

Publication number Publication date
FI823580L (fi) 1983-04-22
JPS5888369A (ja) 1983-05-26
AU551938B2 (en) 1986-05-15
US4499092A (en) 1985-02-12
FR2514765A1 (fr) 1983-04-22
FI823580A0 (fi) 1982-10-20
AU8962882A (en) 1983-04-28
YU43528B (en) 1989-08-31
DK156063B (da) 1989-06-19
EP0079810A1 (fr) 1983-05-25
HU187579B (en) 1986-01-28
EP0079810B1 (fr) 1986-01-22
ATE17576T1 (de) 1986-02-15
CS229692B2 (en) 1984-06-18
IE53653B1 (en) 1989-01-04
NO823491L (no) 1983-04-22
PT75667B (fr) 1985-01-11
NO164167C (no) 1990-09-05
IL66960A0 (en) 1983-02-23
FI73982C (fi) 1987-12-10
DK465182A (da) 1983-04-22
NO164167B (no) 1990-05-28
SU1299511A3 (ru) 1987-03-23
DE3268699D1 (en) 1986-03-06
DK156063C (da) 1989-11-13
FI73982B (fi) 1987-08-31
IE822447L (en) 1983-04-21
ES516694A0 (es) 1983-07-01
KR840001968A (ko) 1984-06-07
PT75667A (fr) 1982-11-01
ES8307226A1 (es) 1983-07-01
CA1236102A (en) 1988-05-03
NZ202237A (en) 1985-08-30
DD210040A5 (de) 1984-05-30
FR2514765B1 (xx) 1984-04-06
GR76535B (xx) 1984-08-10
YU223382A (en) 1984-10-31
KR880001077B1 (ko) 1988-06-22

Similar Documents

Publication Publication Date Title
HUT50786A (en) Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components
DE3366141D1 (en) 1-phenylisoquinoline derivatives, process for their preparation, pharmaceutical compositions containing these compounds and their use
AU3923789A (en) Diorganopolysiloxane derivatives, their preparation and their use
ES8207532A1 (es) Procedimiento para la preparacion de xantinas di- o tri- substituidas
DE3268699D1 (en) Derivatives of 4-phenyl-quinazoline active on the central nervous system
IL87490A0 (en) Pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for the treatment of alcoholism
ZA836663B (en) Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof
IE56209B1 (en) Piperidinedione derivatives,processing anti-arrythmic activity,for protecting the myocardium,process for their preparation and pharmaceutical compositions containing said derivatives
EP0234348A3 (en) N-glycosyl amide derivatives, method for their preparation and their use as medicaments
IL95166A0 (en) Renin-inhibiting amino oligohydroxy derivatives
ES8800924A1 (es) Procedimiento para la obtencion de benzotiopiranonas
IL87198A0 (en) Leukotriene antagonists,a process for the preparation thereof and pharmaceutical compositions containing them
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ES8606298A1 (es) 1.4-dihidropirazinas
IL105599A0 (en) Enantiomers derived from(s)-2-amino-2(3,4-dichlorobenzyl)-1-propanol and pharmaceutical compositions containing same
GR3022125T3 (en) Process for the preparation of 1,3-dialkyl-5-hydroxyoxindoles and of their ether derivatives
KR900014372A (ko) 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제